HOLX 240517 75.00C (HOLX240517C75000) 股票期權、新聞、報價

0.05
-0.12-70.59%

延時15分鐘行情收盤價 05/17 15:59 (美東)

0.20最高價0.03最低價

代碼股票名稱

最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業

評論

Trytosaveabit

04/11 13:11

Update

$豪洛捷(HOLX.US)$ Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography 3 MINUTES AGO, 2:07 PM EDT VIA BUSINESSWIRE Collaboration Includes Robust Education and Training to Support Radiologists and Imaging Specialists Bayer and Hologic, Inc. (NASDAQ:HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two ...

Moomoo AI

02/12 09:38

Multiple insiders selling shares could be a red flag. The absence of insider purchases and significant selling over the last three months may suggest insiders believe the shares are overpriced. Despite high insider ownership, the lack of buying and significant selling raises concerns about the company.

Possible Bearish Signals With Hologic Insiders Disposing Stock

Moomoo AI

2023/11/21 06:16

Undervalued Hologic presents opportunity to accumulate stocks. Investors cautioned to consider financial health. Company's outlook suggests further growth not reflected in share price.

Is Now An Opportune Moment To Examine Hologic, Inc. (NASDAQ:HOLX)?

逍遥投资派

2023/06/18 10:50

$豪洛捷(HOLX.US)$5年來營收前四年增長，2022年下滑13.7%，5年平均增速9.7%，營業利潤受毛利率變化影響很大，劇烈波動中在2021年增長到了24.8億，2022年又下滑34.3%到16.3億。淨利潤則在2020年扭虧，2021年達到18.7億的高點，2022年下滑30%到13億。
2023前兩季度營收大幅下滑27.7%，營業利潤下滑57.4%，淨利潤下滑57.5%。
目前市盈率15.8，市盈率TTM已經上升到了27，缺乏吸引力。

已翻譯

FrankieSmilez

2023/05/10 13:10

$梯瓦製藥(TEVA.US)$ $丘奇&德懷特(CHD.US)$ $豪洛捷(HOLX.US)$ $Dare Bioscience(DARE.US)$ $Femasys(FEMY.US)$ $輝瑞(PFE.US)$ Breaking News